Accelerating GMP Tech Transfer: Translating Novel Radiopharmaceutical Platforms from Discovery to First-in Human

• Preparing novel radiopharmaceutical technologies for successful GMP tech transfer and clinical manufacturing
• Lessons learned navigating analytical, CMC and operational challenges during technology transfer • Coordinating discovery, manufacturing and clinical teams to enable seamless progression into Phase I
• Key considerations for de-risking technology transfer while maintaining programme momentum

Speakers:

Rich Edwards

Chief Technology Officer

Nuclide Therapeutics